Publication | Closed Access

The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine

Lymphoid NeoplasiaHealth SciencesMalignant Blood DisorderCell ProliferationReduced Growth RateAnti-cancer AgentCell BiologyHob1 Lymphoma CellsMedicineRadiation OncologyTumor MicroenvironmentCancer ResearchCancer GrowthDrug Resistance